PL1933861T3 - Sposób leczenia lub zapobiegania niewydolności wielonarządowej - Google Patents

Sposób leczenia lub zapobiegania niewydolności wielonarządowej

Info

Publication number
PL1933861T3
PL1933861T3 PL06794084T PL06794084T PL1933861T3 PL 1933861 T3 PL1933861 T3 PL 1933861T3 PL 06794084 T PL06794084 T PL 06794084T PL 06794084 T PL06794084 T PL 06794084T PL 1933861 T3 PL1933861 T3 PL 1933861T3
Authority
PL
Poland
Prior art keywords
treating
organ failure
preventing multi
preventing
organ
Prior art date
Application number
PL06794084T
Other languages
English (en)
Inventor
Sirpa Jalkanen
Original Assignee
Faron Pharmaceuticals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faron Pharmaceuticals Oy filed Critical Faron Pharmaceuticals Oy
Publication of PL1933861T3 publication Critical patent/PL1933861T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06794084T 2005-10-07 2006-09-22 Sposób leczenia lub zapobiegania niewydolności wielonarządowej PL1933861T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20051003A FI20051003A0 (fi) 2005-10-07 2005-10-07 Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi
PCT/FI2006/000308 WO2007042602A1 (en) 2005-10-07 2006-09-22 Method for treating or preventing ischemia reperfusion injury or multi-organ failure
EP06794084A EP1933861B1 (en) 2005-10-07 2006-09-22 Method for treating or preventing multi-organ failure

Publications (1)

Publication Number Publication Date
PL1933861T3 true PL1933861T3 (pl) 2012-12-31

Family

ID=35185146

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06794084T PL1933861T3 (pl) 2005-10-07 2006-09-22 Sposób leczenia lub zapobiegania niewydolności wielonarządowej

Country Status (13)

Country Link
EP (1) EP1933861B1 (pl)
JP (2) JP5523707B2 (pl)
CN (1) CN101282741B (pl)
AU (1) AU2006301186B2 (pl)
CA (1) CA2623518C (pl)
CY (1) CY1113404T1 (pl)
DK (1) DK1933861T3 (pl)
ES (1) ES2389507T3 (pl)
FI (1) FI20051003A0 (pl)
PL (1) PL1933861T3 (pl)
PT (1) PT1933861E (pl)
SI (1) SI1933861T1 (pl)
WO (1) WO2007042602A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8114630B2 (en) 2007-05-02 2012-02-14 Ambrx, Inc. Modified interferon beta polypeptides and their uses
FI20070795A0 (fi) 2007-10-24 2007-10-24 Faron Pharmaceuticals Oy Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin
US8659835B2 (en) 2009-03-13 2014-02-25 Optotune Ag Lens systems and method
US8699141B2 (en) 2009-03-13 2014-04-15 Knowles Electronics, Llc Lens assembly apparatus and method
KR101451357B1 (ko) * 2011-02-18 2014-10-15 주식회사 스템디알 Ｓｉｒｔ１ 발현 유도 물질을 포함하는 패혈증 또는 패혈증 쇼크의 예방 또는 치료용 조성물
WO2020115368A1 (en) * 2018-12-04 2020-06-11 Faron Pharmaceuticals Oy Method for determining patient's responsiveness to type i interferon treatment and use of type i interferon to treat patient having specified single nucleotide polymorphism
AU2022210842A1 (en) 2021-01-25 2023-08-03 Faron Pharmaceuticals Oy Treatment of diseases with sequential administration of an agent capable of up-regulating cd73 and glucocorticoids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60129472T2 (de) * 2001-04-03 2008-04-17 U-Cytech B.V. Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon
AU2002310922A1 (en) * 2001-05-04 2002-11-18 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia
JP2004536819A (ja) * 2001-06-11 2004-12-09 トランジション・セラピューティックス・インコーポレーテッド ウイルス性、増殖性および炎症性の疾患の治療のためにビタミンｂ１２および治療薬を用いた複合治療
US20050106138A1 (en) * 2001-09-18 2005-05-19 Hamid Rabb Specific depletion of cd4+ t cells
US20060083715A1 (en) * 2002-03-12 2006-04-20 Steven Glazer Interferon beta-like molecules for treatment of stroke
US7534423B2 (en) * 2003-03-28 2009-05-19 Faron Pharmaceuticals Oy Method for inducing an elevated level of adenosine in an individual

Also Published As

Publication number Publication date
JP5523707B2 (ja) 2014-06-18
CA2623518A1 (en) 2007-04-19
DK1933861T3 (da) 2012-10-15
AU2006301186A1 (en) 2007-04-19
CN101282741A (zh) 2008-10-08
EP1933861A1 (en) 2008-06-25
CA2623518C (en) 2014-11-18
CN101282741B (zh) 2012-08-15
PT1933861E (pt) 2012-08-20
WO2007042602A1 (en) 2007-04-19
JP2013028623A (ja) 2013-02-07
JP2009511453A (ja) 2009-03-19
HK1125048A1 (en) 2009-07-31
CY1113404T1 (el) 2016-06-22
EP1933861B1 (en) 2012-08-08
FI20051003A0 (fi) 2005-10-07
SI1933861T1 (sl) 2012-09-28
AU2006301186B2 (en) 2011-08-04
ES2389507T3 (es) 2012-10-26
EP1933861A4 (en) 2009-07-01

Similar Documents

Publication Publication Date Title
PL1877232T3 (pl) Sposób obróbki powierzchni drewna
IL191118A0 (en) Method for treating joint damage
GB0504774D0 (en) Method
EP1864785A4 (en) SETEROLITHOGRAPHIEVERFAHREN
IL183889A0 (en) Treatment method
GB0503836D0 (en) Method
EP2081437A4 (en) METHODS OF TREATING OR PREVENTING INFESTATION
GB0504096D0 (en) Method
GB0509433D0 (en) Method
GB0504184D0 (en) Method
GB0507123D0 (en) Method
PL1843880T3 (pl) Sposób obróbki drewna
SI1933861T1 (sl) Postopek za zdravjenje ali preprečevanje večorganske odpovedi
EP1883405A4 (en) METHODS OF TREATING NEPHROLITHIASIS
GB0526664D0 (en) Method
GB0505756D0 (en) Method
GB0508420D0 (en) Method
GB0502046D0 (en) Method
GB0509305D0 (en) Method
ZA200706456B (en) Method for treating liquids
GB0508622D0 (en) Method for treating effluent
GB0502901D0 (en) New detoxification method
GB0504182D0 (en) Method
GB0506670D0 (en) Method
GB0502360D0 (en) Method